Genetic News and Research

RSS

Genetic marker linked to higher risk of death in COVID-19 patients

A new study discusses the importance of single nucleotide polymorphisms in the Rab46 gene as a marker of adverse outcomes in high-risk COVID-19 patients.

23 Jan 2022

Scientists develop new drug delivery system for treating genetic diseases

A team of researchers led by Harvard and Broad Institute scientists has developed a new drug delivery system using engineered DNA-free virus-like particles (eVLPs) to package and deliver therapeutic levels of gene-editing proteins to animal models of disease.

22 Jan 2022

Researchers call for more work to address unmet needs of women with Parkinson's disease

Researchers in a multi-institution study led by UCLA Health have identified several overlooked issues affecting women with Parkinson's Disease (PD) and call for more research, customized treatments, education and support to empower women living with this disease and to address their unmet medical needs.

22 Jan 2022

Omicron found to have higher environmental stability among SARS-CoV-2 variants

A new study compared the SARS-CoV-2 Wuhan strain and all the variants of concern (VOCs) - Alpha, Beta, Delta, and Omicron variants for their survivability and infectivity.

21 Jan 2022

New COVID-19 vaccine promises vaccine equity because it has no patents

Corbevax, a new vaccine against COVID-19, may have better success as a candidate for vaccine equity because it carries no patents, relies on long-established recombinant technology for manufacture and has the support of the US and Indian governments, its makers and health experts say.

21 Jan 2022

High-speed cell sorter uses fluorescence imaging to enable genome-scale studies of complex phenotypes

Isolating individual cells with complex phenotypes – which is key to understanding how these cells function, including to inform disease – is a technological challenge. Now, overcoming this hurdle, researchers present a high-speed cell sorter that uses fluorescence imaging to enable genome-scale studies of complex phenotypes.

21 Jan 2022

CENTOGENE teams up with Insilico Medicine to improve therapeutic targets for Niemann-Pick disease type C

A commercial-stage company focused on generating data-driven insights to diagnose, understand and treat rare diseases, and Insilico Medicine, an end-to-end Artificial Intelligence (AI) - driven drug discovery company, today announced a research and development collaboration to accelerate the discovery of novel therapeutic targets for Niemann-Pick disease type C

21 Jan 2022

Fully dynamic kinetic model of a living 'minimal cell' offers insight into basic principles of life

Scientists report that they have built a living "minimal cell" with a genome stripped down to its barest essentials – and a computer model of the cell that mirrors its behavior.

20 Jan 2022

UC San Diego receives $14.55 million to launch new Microbiome and Metagenomics Center

The National Institutes of Health's All of Us Research Program is a national effort to build a large, diverse database of 1 million or more people whom researchers can use to study health and disease.

20 Jan 2022

Mice study identifies ventral spinocerebellar tract neurons that control locomotion

For more than a century, scientists have known that while the commands that initiate movement come from the brain, the neurons that control locomotion once movement is underway reside within the spinal cord.

20 Jan 2022

Researchers identify first known patients with BUB1 biallelic mutations

A new study published in Science Advances described the first two patients known to have mutations in both copies of BUB1, a critical gene for cell division.

20 Jan 2022

UAB research outlines successful xenotransplantation of genetically modified kidneys

The University of Alabama at Birmingham Marnix E. Heersink School of Medicine announces today the first peer-reviewed research outlining the successful transplant of genetically modified, clinical-grade pig kidneys into a brain-dead human individual, replacing the recipient's native kidneys.

20 Jan 2022

Intense, regular walking may help prevent Type 2 diabetes among 70 and 80 year olds

Walking regularly and at greater intensity may help prevent Type 2 diabetes among 70 and 80 year olds, according to one of the first studies measuring steps and pace among this population.

20 Jan 2022

New cryo-EM method may be able to shortcut a big step in modern vaccine development

Scientists at Scripps Research have devised a method that may be able to shortcut one of the big steps in modern vaccine development.

20 Jan 2022

Environmental risk factors driving the nearsightedness 'epidemic' in the UK

A team of researchers used the UK Biobank Study to investigate whether changing environmental factors are causing an increase in myopia.

20 Jan 2022

Newly developed gene therapy can treat a severe form of epilepsy and prolong survival

Research from the University of Virginia School of Medicine suggests how a newly developed gene therapy can treat Dravet syndrome, a severe form of epilepsy, and potentially prolong survival for people with the condition.

20 Jan 2022

Study finds no proof of recently infected mothers transmitting SARS-CoV-2 through breastmilk

There is no evidence of recently infected mothers transmitting infectious SARS-CoV-2 through breastmilk to their baby, reports a study published in the journal Pediatric Research.

20 Jan 2022

New findings could contribute to future therapeutics for muscle degeneration

An international team led by uOttawa Faculty of Medicine researchers have published findings that could contribute to future therapeutics for muscle degeneration due to old age, and diseases such as cancer and muscular dystrophy.

19 Jan 2022

Positive childhood environments may help buffer the physiological effects of adversity and trauma

Researchers know that experiencing a high number of adverse events in childhood correlates with worse health outcomes in adulthood. These studies have led to an emphasis on trauma-informed practice in schools and workplaces in an attempt to mitigate the harm of early adversity.

19 Jan 2022

Study identifies a new potential pathway for developing therapeutics against Epstein-Barr virus

A new study by researchers at The Wistar Institute, an international biomedical research leader in cancer, immunology, infectious disease, and vaccine development, has identified a new potential pathway for developing therapeutics that target Epstein-Barr virus (EBV).

19 Jan 2022

Genetic News and Research

Genetic marker linked to higher risk of death in COVID-19 patients

Scientists develop new drug delivery system for treating genetic diseases

Researchers call for more work to address unmet needs of women with Parkinson's disease

Omicron found to have higher environmental stability among SARS-CoV-2 variants

New COVID-19 vaccine promises vaccine equity because it has no patents

High-speed cell sorter uses fluorescence imaging to enable genome-scale studies of complex phenotypes

CENTOGENE teams up with Insilico Medicine to improve therapeutic targets for Niemann-Pick disease type C

Fully dynamic kinetic model of a living 'minimal cell' offers insight into basic principles of life

UC San Diego receives $14.55 million to launch new Microbiome and Metagenomics Center

Mice study identifies ventral spinocerebellar tract neurons that control locomotion

Researchers identify first known patients with BUB1 biallelic mutations

UAB research outlines successful xenotransplantation of genetically modified kidneys

Intense, regular walking may help prevent Type 2 diabetes among 70 and 80 year olds

New cryo-EM method may be able to shortcut a big step in modern vaccine development

Environmental risk factors driving the nearsightedness 'epidemic' in the UK

Newly developed gene therapy can treat a severe form of epilepsy and prolong survival

Study finds no proof of recently infected mothers transmitting SARS-CoV-2 through breastmilk

New findings could contribute to future therapeutics for muscle degeneration

Positive childhood environments may help buffer the physiological effects of adversity and trauma

Study identifies a new potential pathway for developing therapeutics against Epstein-Barr virus

eBook: Using iPSCs models for human disease research and drug discovery eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News